AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ISLAND PHARMACEUTICALS LTD

0.365

0.000

Volume:155.00K

Turnover:56.97K

Market Cap:107.59M

PE:-10.03

High:0.370

Open:0.370

Low:0.365

Close:0.365

52wk High:0.630

52wk Low:0.310

Shares:294.77M

Float Shares:110.76M

Volume Ratio:0.55

T/O Rate:0.14%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.036

EPS(LYR):-0.036

ROE:-95.50%

ROA:-60.12%

PB:7.99

PE(LYR):-10.03

Loading ...

Overview Company News Filings

Island Pharmaceuticals - Trading Halt Pending Announcement on Galidesivir Use in Ebola Clinical Trial in Africa

THOMSON REUTERS

Island Pharmaceuticals Says Singapore Granted Patent for Antiviral Therapy; Shares Jump 4%

MT Newswires Live

Island Pharmaceuticals Secures US FDA Orphan Drug Status for Antiviral Candidate

MT Newswires Live

Island Pharmaceuticals Ltd-FDA Grants Orphan Designation for Galidesivir in Marburg

THOMSON REUTERS

Island Pharmaceuticals Ltd-Investor Presentation (Updated)

THOMSON REUTERS

BUZZ-Australia's Island Pharmaceuticals rises on agreement extension with US Army

Island Pharmaceuticals Secures Agreement Expansion With US Army Medical Research Institute of Infectious Diseases; Shares Up 3%

MT Newswires Live

Island Pharmaceuticals Ltd-Island Secures Usamriid Support for Galidesivir Study

THOMSON REUTERS

BRIEF-Island Pharmaceuticals Says GMP Manufacturing Of Galidesivir Commenced

Island Pharmaceuticals Ltd - Gmp Manufacturing of Galidesivir Commenced to Support Pivotal Marburg Study Under US FDA's Animal Rule Pathway

THOMSON REUTERS

Island Pharmaceuticals Ltd - Executed Agreement With Pi Health Sciences

THOMSON REUTERS

When Can We Expect A Profit From Island Pharmaceuticals Limited (ASX:ILA)?

Simply Wall St.

Island Pharmaceuticals Appoints Senior Global Health Security Adviser Ahead of Animal Rule Studies for Antiviral Drug Candidate; Shares Drop 6%

MT Newswires Live

Island Pharmaceuticals Works Alongside USAMRIID to Advance Clinical Development For Galidesivir

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/ILA.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ILA.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ILA.AU\",,,,,undefined,":{"symbol":"ILA.AU","market":"AU","secType":"STK","nameCN":"ISLAND PHARMACEUTICALS LTD","latestPrice":0.365,"timestamp":1790835120000,"preClose":0.365,"halted":0,"volume":154995,"delay":0,"changeRate":0,"nameEN":"ISLAND PHARMACEUTICALS LTD","floatShares":110756995,"shares":294766682,"eps":-0.0364,"marketStatus":"Not Yet Opened","change":0,"latestTime":"10-01 16:12:00 AEST","open":0.37,"high":0.37,"low":0.365,"amount":56967,"amplitude":0.013699,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.0364,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1790899200000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.365,"openAndCloseTimeList":[[1790812800000,1790834400000]],"volumeRatio":0.5461324119058737,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ILA.AU","preClose":0.365,"auctionPrice":0.365,"auctionVolume":31986,"auction":3,"marketStatus":"盘后竞价","timestamp":1790835001948}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ILA.AU\",,,,,undefined,":{"symbol":"ILA.AU","floatShares":110756995,"roa":"-60.12%","roe":"-95.50%","lyrEps":-0.0364,"volumeRatio":0.5461324119058737,"shares":294766682,"dividePrice":0,"high":0.37,"amplitude":0.013699,"preClose":0.365,"low":0.365,"week52Low":0.31,"pbRate":"7.99","psRate":"380.64","week52High":0.63,"institutionHeld":0,"latestPrice":0.365,"eps":-0.0364,"divideRate":0,"volume":154995,"delay":0,"ttmEps":-0.0364,"open":0.37,"prevYearClose":0.43,"prevWeekClose":0.4,"prevMonthClose":0.365,"prevQuarterClose":0.365,"fiveDayClose":0.405,"twentyDayClose":0.44,"sixtyDayClose":0.45,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ILA.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ILA.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ILA.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2648763712","title":"Island Pharmaceuticals - Trading Halt Pending Announcement on Galidesivir Use in Ebola Clinical Trial in Africa","url":"https://stock-news.laohu8.com/highlight/detail?id=2648763712","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648763712?lang=en_us&edition=fundamental","pubTime":"2026-07-03 10:23","pubTimestamp":1783045394,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260703:nFWN43410R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ILA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648527257","title":"Island Pharmaceuticals Says Singapore Granted Patent for Antiviral Therapy; Shares Jump 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648527257","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648527257?lang=en_us&edition=fundamental","pubTime":"2026-07-02 08:33","pubTimestamp":1782952381,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  said Singapore's Intellectual Property Office granted a patent covering the use of its ISLA-101 drug candidate for the treatment of flavivirus and Chikungunya virus infections, according to a Thursday filing with the Australian bourse.Chikungunya is a mosquito-borne viral disease similar to dengue, which is also covered in the patent.The patent is owned by Monash University and protects the use of ISLA-101 as a standalone antiviral therapy until April 16, 2034, per the filing.\"Singapore is an important market within the Asia-Pacific region, where dengue and other mosquito-borne viral diseases remain endemic,\" the company said.The company's shares jumped 4% in recent Thursday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ILA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644532796","title":"Island Pharmaceuticals Secures US FDA Orphan Drug Status for Antiviral Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2644532796","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644532796?lang=en_us&edition=fundamental","pubTime":"2026-06-17 07:45","pubTimestamp":1781653529,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  secured an Orphan Drug Designation from the US Food and Drug Administration  for its antiviral candidate Galidesivir as a post-exposure prophylaxis for Marburg virus disease, according to a Wednesday filing with the Australian bourse.The designation offers regulatory and commercial benefits, including up to seven years of US market exclusivity if approved, along with fee waivers and increased FDA support, per the filing.The company also noted recent progress, including an expanded Cooperative Research and Development Agreement with the US Army Medical Research Institute of Infectious Diseases, securing a non-human primate supply for upcoming dose-optimization studies, and initiating GMP manufacturing.The company said that preparations for pivotal studies are ongoing, with the next development phase expected to start in the next quarter, the filing added.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ILA.AU","LABU","BK4585","BK7096","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644795911","title":"Island Pharmaceuticals Ltd-FDA Grants Orphan Designation for Galidesivir in Marburg","url":"https://stock-news.laohu8.com/highlight/detail?id=2644795911","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644795911?lang=en_us&edition=fundamental","pubTime":"2026-06-17 06:54","pubTimestamp":1781650497,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nTUE2RNGHD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ILA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642408360","title":"Island Pharmaceuticals Ltd-Investor Presentation (Updated)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642408360","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642408360?lang=en_us&edition=fundamental","pubTime":"2026-06-11 10:25","pubTimestamp":1781144724,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nTUE4SVDLR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642106594","title":"BUZZ-Australia's Island Pharmaceuticals rises on agreement extension with US Army","url":"https://stock-news.laohu8.com/highlight/detail?id=2642106594","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642106594?lang=en_us&edition=fundamental","pubTime":"2026-06-10 13:56","pubTimestamp":1781070963,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Island Pharmaceuticals rises on agreement extension with US Army** Shares of Australia's Island Pharmaceuticals ILA.AX rise as much as 5.7% to A$0.37, their biggest intraday pct gain since May 21** The antiviral drug developer says it extends its existing cooperative research and development agreement  with the U.S. Army** Says the agreement advances the company's dose optimisation study evaluating Galidesivir for the treatment of fatal viral fever, Marburg Virus Disease** Says this allows company to prepare for operations and commercialization of the drug** YTD, stock down 15.1%, including day's moves  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nL6N42I0CB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ILA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642416204","title":"Island Pharmaceuticals Secures Agreement Expansion With US Army Medical Research Institute of Infectious Diseases; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2642416204","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642416204?lang=en_us&edition=fundamental","pubTime":"2026-06-10 09:15","pubTimestamp":1781054126,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  secured an expansion to its cooperative research and development agreement with the US Army Medical Research Institute of Infectious Diseases, a part of the Defense Health Agency and The Geneva Foundation for Medical Research, according to a Wednesday filing with the Australian bourse.The expanded agreement confirms the company's planned dose optimization study evaluating Galidesivir, its treatment candidate for Marburg virus disease, the filing said.The study is expected to start next quarter with topline results in the second half of the year, per the filing.Shares rose 3% in morning trade on Wednesday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642133304","title":"Island Pharmaceuticals Ltd-Island Secures Usamriid Support for Galidesivir Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2642133304","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642133304?lang=en_us&edition=fundamental","pubTime":"2026-06-10 06:53","pubTimestamp":1781045614,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nTUE2RNK6H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640180822","title":"BRIEF-Island Pharmaceuticals Says GMP Manufacturing Of Galidesivir Commenced","url":"https://stock-news.laohu8.com/highlight/detail?id=2640180822","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640180822?lang=en_us&edition=fundamental","pubTime":"2026-06-04 07:22","pubTimestamp":1780528978,"startTime":"0","endTime":"0","summary":"BRIEF-Island Pharmaceuticals Says GMP Manufacturing Of Galidesivir CommencedJune 4  - Island Pharmaceuticals Ltd ILA.AX:GMP MANUFACTURING OF GALIDESIVIR COMMENCED TO SUPPORT PIVOTAL MARBURG STUDY UNDER US FDA'S ANIMAL RULE PATHWAYEXECUTED AGREEMENT WITH PI HEALTH SCIENCESFurther company coverage: ILA.AX ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nFWN42B10F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ILA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640877331","title":"Island Pharmaceuticals Ltd - Gmp Manufacturing of Galidesivir Commenced to Support Pivotal Marburg Study Under US FDA's Animal Rule Pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2640877331","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640877331?lang=en_us&edition=fundamental","pubTime":"2026-06-04 07:04","pubTimestamp":1780527851,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nFWN42B10F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ILA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640187735","title":"Island Pharmaceuticals Ltd - Executed Agreement With Pi Health Sciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2640187735","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640187735?lang=en_us&edition=fundamental","pubTime":"2026-06-04 07:04","pubTimestamp":1780527851,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nFWN42B10F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636456832","title":"When Can We Expect A Profit From Island Pharmaceuticals Limited (ASX:ILA)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2636456832","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636456832?lang=en_us&edition=fundamental","pubTime":"2026-05-19 13:51","pubTimestamp":1779169917,"startTime":"0","endTime":"0","summary":"With the business potentially at an important milestone, we thought we'd take a closer look at Island Pharmaceuticals...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-ila/island-pharmaceuticals-shares/news/when-can-we-expect-a-profit-from-island-pharmaceuticals-limi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-ila/island-pharmaceuticals-shares/news/when-can-we-expect-a-profit-from-island-pharmaceuticals-limi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ILA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636588169","title":"Island Pharmaceuticals Appoints Senior Global Health Security Adviser Ahead of Animal Rule Studies for Antiviral Drug Candidate; Shares Drop 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636588169","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636588169?lang=en_us&edition=fundamental","pubTime":"2026-05-19 11:55","pubTimestamp":1779162957,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  appointed US biodefense executive Mark Herzog as senior global health security adviser ahead of the start of its Animal Rule studies for galidesivir in Marburg virus disease, according to a Tuesday Australian bourse filing.Marburg virus disease, formerly known as Marburg haemorrhagic fever, is a fatal illness caused by the Marburg virus, according to the World Health Organization website.The company said it is on track to begin planned dose optimization studies in the September quarter, adding that it remains in advanced negotiations with US-based BSL-4 biocontainment facilities regarding the execution of its planned two-stage development pathway.Island Pharmaceuticals' shares dropped 6% in recent trading on Tuesday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630351272","title":"Island Pharmaceuticals Works Alongside USAMRIID to Advance Clinical Development For Galidesivir","url":"https://stock-news.laohu8.com/highlight/detail?id=2630351272","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630351272?lang=en_us&edition=fundamental","pubTime":"2026-04-27 13:07","pubTimestamp":1777266438,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals' (ASX:ILA) work alongside the US Army Medical Research Institute of Infectious Diseases (USAMRIID) and Texas Biomedical Research Institute is well progressed, with the next phas","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":34,"code":"91000000","status":"200"}]}}